clinical drainage News
1 news items found
-
Lung Therapeutics, Inc. Doses First Patient in Phase 1 Clinical Trial of Lti-01 in Australia and New Zealand
LTI-01 addresses unmet needs in a $600+ million global market. Intended to replace costly surgery and ineffective off-label treatments of fibrosis, the drug can provide safer and more cost-effective therapeutic options for CPE/empyema patients and healthcare providers worldwide. Lung Therapeutics, Inc., a clinical stage pharmaceutical company focused on niche, orphan drug indications in ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you